These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21733485)

  • 1. Metabolic syndrome in inpatients treated with clozapine.
    Suzuki T
    J Clin Psychiatry; 2011 Jun; 72(6):872-3; author reply 873-4. PubMed ID: 21733485
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of weight gain and metabolic syndrome in patients taking clozapine: an 8-year cohort study.
    Bai YM; Lin CC; Chen JY; Chen TT; Su TP; Chou P
    J Clin Psychiatry; 2011 Jun; 72(6):751-6. PubMed ID: 21208584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine and cardiometabolic health in chronic schizophrenia: correlations and consequences in a clinical context.
    Malhi G; Adams D; Plain J; Coulston C; Herman M; Walter G
    Australas Psychiatry; 2010 Feb; 18(1):32-41. PubMed ID: 20039791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does antipsychotic polypharmacy increase the risk for metabolic syndrome?
    Correll CU; Frederickson AM; Kane JM; Manu P
    Schizophr Res; 2007 Jan; 89(1-3):91-100. PubMed ID: 17070017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia.
    Lee NY; Roh MS; Kim SH; Jung DC; Yu HY; Sung KH; Chung IW; Youn T; Kang UG; Ahn YM; Kim YS
    Int Clin Psychopharmacol; 2013 Mar; 28(2):71-9. PubMed ID: 23211493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of obese, clozapine-treated inpatients with schizophrenia placed on a six-month diet and physical activity program.
    Wu MK; Wang CK; Bai YM; Huang CY; Lee SD
    Psychiatr Serv; 2007 Apr; 58(4):544-50. PubMed ID: 17412858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delusion of pregnancy associated with antipsychotic induced metabolic syndrome.
    Manjunatha N; Saddichha S
    World J Biol Psychiatry; 2009; 10(4 Pt 2):669-70. PubMed ID: 19096992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabolic syndrome in patients with schizophrenia and antipsychotic treatment].
    Aguilar E; Coronas R; Caixàs A
    Med Clin (Barc); 2012 Nov; 139(12):542-6. PubMed ID: 22841467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of ethnicity on metabolic outcomes during treatment with antipsychotics: complexities abound.
    Citrome L; Krakowski M
    J Clin Psychiatry; 2009 Nov; 70(11):1608-9. PubMed ID: 20031109
    [No Abstract]   [Full Text] [Related]  

  • 10. Metformin-induced acute dystonia in a schizophrenic patient treated with sulpiride and clozapine.
    Chen WH; Huang WL; Hsieh MH
    Psychiatry Clin Neurosci; 2016 Aug; 70(8):362-3. PubMed ID: 27193328
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic syndrome and antipsychotic monotherapy treatment among schizophrenia patients in Malaysia.
    Said MA; Hatim A; Habil MH; Zafidah W; Haslina MY; Badiah Y; Ramli MA; Ananjit S; Sapini Y; Shah M; Mahmud B; Bulgiba A; Hairi NN
    Prev Med; 2013; 57 Suppl():S50-3. PubMed ID: 23337566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions.
    Birkenaes AB; Birkeland KI; Engh JA; Faerden A; Jonsdottir H; Ringen PA; Friis S; Opjordsmoen S; Andreassen OA
    J Clin Psychopharmacol; 2008 Apr; 28(2):132-7. PubMed ID: 18344722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between HTR2C polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics.
    Bai YM; Chen TT; Liou YJ; Hong CJ; Tsai SJ
    Schizophr Res; 2011 Feb; 125(2-3):179-86. PubMed ID: 21185157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A twenty-four-week, open-label study on ziprasidone's efficacy and influence on glucolipid metabolism in patients with schizophrenia and metabolic disorder.
    Li CH; Shi L; Zhan GL; Rao SZ; Zhang H
    Eur Rev Med Pharmacol Sci; 2013 Aug; 17(16):2136-40. PubMed ID: 23893178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine alone versus clozapine and risperidone for refractory schizophrenia.
    Gerson SL
    N Engl J Med; 2006 Apr; 354(17):1846-8; author reply 1846-8. PubMed ID: 16642587
    [No Abstract]   [Full Text] [Related]  

  • 16. Sweet's syndrome and polyserositis with clozapine.
    Schonfeldt-Lecuona C; Connemann BJ
    Am J Psychiatry; 2002 Nov; 159(11):1947. PubMed ID: 12411238
    [No Abstract]   [Full Text] [Related]  

  • 17. Clozapine-associated weight loss.
    Hanwella R; de Silva V; Wijeratne C; Ketharanathan T; de Silva J
    J Psychopharmacol; 2010 Jul; 24(7):1127-9. PubMed ID: 19264815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between HTR2C and HTR2A polymorphisms and metabolic abnormalities in patients treated with olanzapine or clozapine.
    Gunes A; Melkersson KI; Scordo MG; Dahl ML
    J Clin Psychopharmacol; 2009 Feb; 29(1):65-8. PubMed ID: 19142110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clozapine in the treatment of schizophrenia].
    Raitasuo V
    Duodecim; 2000; 116(11):1199-204; quiz 1205. PubMed ID: 11989005
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome related to use of clozapine.
    Trayer JS; Fidler DC
    J Am Osteopath Assoc; 1998 Mar; 98(3):168-9. PubMed ID: 9558834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.